Discovery To Commence In Invitrogen Patent Case

Law360, New York (October 4, 2007, 12:00 AM EDT) -- Life sciences company Invitrogen Corp. has won the go-ahead to commence limited discovery in a lawsuit that accuses Harvard College's top guardians of wrongly laying claim to a molecular cloning patent.

In an order issued Thursday, Magistrate Judge Louisa S. Porter of the U.S. District Court for the Southern District of California said Invitrogen was not required to establish a prima facie case of personal jurisdiction prior to conducting discovery.

However, she did say Invitrogen's discovery requests were overly burdensome, and therefore partially granted Harvard's motion...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.